v3.21.2
Net Income (Loss) Per Share from Continuing Operations
 9 Months Ended
Oct. 01, 2021
Earnings Per Share [Abstract]  
Net Income Per Share from Continuing Operations Net Income Per Share from Continuing Operations
Net income per share from continuing operations was computed as follows:
Three Months EndedNine Months Ended
October 1, 2021October 2, 2020October 1, 2021October 2, 2020
(In thousands, except share and per share data)
Computation of Net income per share from continuing operations - basic:
Net income from continuing operations attributable to Colfax Corporation (1)
$27,092 $16,047 $83,915 $20,319 
Weighted-average shares of Common stock outstanding – basic
159,093,384 136,832,909 150,822,061 136,730,112 
Net income per share from continuing operations – basic
$0.17 $0.12 $0.56 $0.15 
Computation of Net income per share from continuing operations - diluted:
Net income from continuing operations attributable to Colfax Corporation (1)
$27,092 $16,047 $83,915 $20,319 
Weighted-average shares of Common stock outstanding – basic
159,093,384 136,832,909 150,822,061 136,730,112 
Net effect of potentially dilutive securities - stock options, restricted stock units and tangible equity units2,073,711 1,257,701 2,076,332 2,339,794 
Weighted-average shares of Common stock outstanding – diluted
161,167,095 138,090,610 152,898,393 139,069,906 
Net income per share from continuing operations – diluted
$0.17 $0.12 $0.55 $0.15 
(1) Net income from continuing operations attributable to Colfax Corporation for the respective periods is calculated using Net income from continuing operations less the income attributable to noncontrolling interest, net of taxes, of $1.0 million and $3.2 million for the three and nine months ended October 1, 2021, respectively, and $0.8 million and $2.2 million for the three and nine months ended October 2, 2020, respectively.

For all periods presented, the weighted-average shares of Common stock outstanding - basic includes the impact of 18.4 million shares related to the issuance of Colfax’s tangible equity units. During the three and nine months ended October 1, 2021, conversions of the Company’s tangible equity units resulted in the issuance of approximately 5.6 million and 12.1 million shares of Colfax common stock, respectively. All issuances of Colfax common stock related to the tangible equity units were converted at the minimum settlement rate 4.0000 shares of common stock for each purchase contract as a result of the Company’s share price. The issued shares are included in the Common stock issued and outstanding as of October 1, 2021. For the nine months ended October 2, 2020, the weighted-average shares of Common stock outstanding - diluted includes the
impact of an additional 1.2 million potentially issuable dilutive shares related to Colfax’s tangible equity units as a result of the Company’s share price in March 2020. See Note 8, “Equity” for details.

The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the three and nine months ended October 1, 2021 excludes 0.8 million and 1.3 million, respectively, of outstanding stock-based compensation awards as their inclusion would be anti-dilutive.

The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the three and nine months ended October 2, 2020 excludes 2.8 million and 4.2 million, respectively, of outstanding stock-based compensation awards as their inclusion would be anti-dilutive.